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Surface topographical features on biomaterials, both at the submicrometre and nanometre scales, are known to influence the
physicochemical interactions between biological processes involving proteins and cells.The nanometre-structured surface features
tend to resemble the extracellularmatrix, the natural environment inwhich cells live, communicate, andwork together. It is believed
that by engineering a well-defined nanometre scale surface topography, it should be possible to induce appropriate surface signals
that can be used to manipulate cell function in a similar manner to the extracellular matrix.Therefore, there is a need to investigate,
understand, and ultimately have the ability to produce tailor-made nanometre scale surface topographies with suitable surface
chemistry to promote favourable biological interactions similar to those of the extracellularmatrix. Recent advances in nanoscience
and nanotechnology have produced many new nanomaterials and numerous manufacturing techniques that have the potential to
significantly improve several fields such as biological sensing, cell culture technology, surgical implants, and medical devices. For
these fields to progress, there is a definite need to develop a detailed understanding of the interaction between biological systems
and fabricated surface structures at both the micrometre and nanometre scales.
1. Introduction
The last two decades have seen a tremendous level of
fundamental research and development into nanotechnol-
ogy. Recent developments in material science, engineering,
biotechnology, and biomedical fields have clearly demon-
strated the many potential applications of nanotechnology [1,
2]. The basis of this intense nanotechnology-based research
is derived from the fact that nanoscale matter can have
significantly different properties than its bulk counterpart
[3, 4]. The discovery and investigation of these unknown
properties, using new advanced characterization techniques,
have the potential to deliver detailed information that can
be used to develop many new nanotechnology-based appli-
cations. These new characterization techniques have come
about from the development of the atomic force microscope
(AFM) and the scanning tunnellingmicroscope (STM) in the
1980s [5]. Both these techniques have given researchers the
unprecedented ability to explore and chart the properties of
these newly created nanomaterials. These newly discovered
nanomaterials have the potential to revolutionize many cur-
rent pharmaceutical and biomedical applications; and along
the way they have the potential to generate new superior tools
to assist in current therapies and provide the foundations for
new avenues of biomedical intervention in the near future.
Currently, there are a number of processing techniques
capable of producing nanomaterials, but recent studies have
focused on refining these processes to produce newnanoscale
materials. A few processes that are currently being investi-
gated and refined to produce high-quality nanomaterials are
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chemical vapour deposition to produce carbon nanotubes
and carbon nanostructures [6, 7], ultrasound techniques to
produce nanohydroxyapatite crystals for biomedical appli-
cations [8, 9] and the wet sol-gel synthesis method for




) nanoparticles [10, 11]. The most
attractive feature of using nanotechnology-based processing
techniques is that it gives the manufacturer far greater
control over the polydiversity, phase, crystalline structure,
topography, morphology, and quality of the nanomaterials
produced.
From a biomedical point of view, the cell is the basic unit
of a biological system and every organism either consists of
cells or is itself a single cell [12]. While cells are generally in
the micrometer-size range, their component structures and
associated environment are generally in the nanometre to
submicrometre range. In fact, the molecular building blocks
of life, such as proteins, carbohydrates, nucleic acids, and
lipids, are all nanometre scale structures. And from the
cellular perspective, the interaction between the cell and
nanometre scale structures such as proteins are crucial for
controlling a variety of cell functions such as proliferation,
migration, and the production of the extracellular matrix
(ECM) (Figure 1) [13]. In addition, the physical structure
and chemistry of the nanometre scale structure directly
influence the behaviour of the cell in contact with the
surface of the nanometre scale structure. For example, when
a biomaterial comes into contact with the internal cellular
environment of the body, proteins spontaneously adsorb
onto the surface. This results in the formation of a surface-
bound protein layer, whichmediates between the biomaterial
surface and the cell surface receptors during subsequent cell
attachment. How the geometrical and chemical properties
of a biomaterial surface influence the adhesive attachment
of the cell to the surface and its subsequent influence on
the proliferation of anchorage-dependent cells is still an
area of active investigation. Furthermore, the adsorption
of proteins to the surface of nanometre scale structures is
highly dependent on the nature of the surface; for example,
surface charge, surface chemistry [14], wettability [15], surface
density of cell-binding ligands [16], and nanotopography [17]
all play an important role in determining the cell-substrate
interaction. In particular, cells are highly sensitive to the local
nanotopographic landscape of the ECM and the substrate.
For example, Yao et al. have shown that the nanometre
topography of bioimplant materials such as Titanium (Ti)




V and anodized Ti) can enhance the
adhesion between osteoblast cells and the surface of the
underlying substrate [18, 19]. Similar studies byWebster et al.
have also revealed an enhanced attachment function between
osteoblast cells and nanoceramic surfaces [20].
2. Tissue Engineering
The field of tissue engineering came into existence during
the mid-1980s to address the high demands for regenerated
tissues in clinical applications. Its creation resulted from
the convergence of several scientific, technological fields,
biotechnology, and medicine. Tissue engineering is still an
Growth factorCell proliferation
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Figure 1: Schematic of the cellular environment.
evolving field whose primary function is to recreate the
appropriate signals to cells that promote biological processes,
which can then create new and/or repair damaged tissues
by rational design. According to Langer and Vacanti, tissue
engineering is a highly interdisciplinary field that combines
engineering principles, biological sciences, and medicine
toward the development of biological substitutes to restore,
replace, maintain, or enhance tissue and organ function [21,
22].
Development over the past few decades in this field
has produced engineered implantable human tissues such as
bone, cartilage, and skin [23, 24]. Currently, there are clinical
trials underway that are investigating the feasibility of using
tissue engineering techniques to produce a human bladder
and blood vessels [23]. The research to date has clearly
demonstrated that a major function of tissue engineering
is to create an environment that can promote productive
and efficient cellular activity; however, this environment is
influenced by a number of tissue-dependent factors. A recent
study by Yang et al. has revealed that tissue engineering is
composed of four key factors: (1) cells, (2) scaffolds, (3) biore-
actors, and (4) signals [25]. To obtain the most beneficial and
effective outcome, an exhaustive examination of these key
factors is needed to achieve the most appropriate contribu-
tion from each step for the particular tissue being addressed.
This equates to determining, developing, and instituting
the most promising environment that can support optimal
survival conditions for the tissue undergoing regeneration.
The first step in any tissue engineering process involves the
harvesting of appropriate cells from donor sites and then
introducing these seed cells into a suitable scaffold structure
contained within a suitable growing medium. The biocom-
patible scaffold structure provides a 3-dimensional (3D) envi-
ronment which promotes cell attachment and proliferation
[26]. Apart from being 3D, the scaffold should be made from
a biocompatible degradable nontoxic material and should be
highly porous to permit the diffusion of nutrients, oxygen,
and waste products [27]. This is where nanotechnology can
have a significant role to play, since nanotechnology permits
the creation of a specialized scaffold structure that can be
specifically designed for the particular cell or tissue type. Fur-
thermore, the scaffold can be enhanced to provide the maxi-
mum environmental conditions for optimal cellular growth.
Many studies have shown that cells in general tend to
behave more naturally when they are cultivated in a 3D
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scaffold environment [28]. This has resulted in the design
of 3D scaffolds that incorporate tissue-specific topographi-
cal and environmental enhancements. These enhancements
are capable of creating an appropriate microenvironment
that can support, regulate, and assist cell function. For
example, cells that were cultivated on scaffolds containing
10–100-𝜇m-sized ridges and grooves promoted elongated cell
growth that was orientated in the direction of the surface
feature [29]. Cells in their natural tissue environment are
generally surrounded by the ECM, a structure composed
of many interwoven fibrous molecules, which forms the
architectural structure capable of supporting and directing
cell behaviour via cell-ECM interactions.The natural scaffold
structure of the ECM is a complex formation of architectural
features such as fibres, pores, and ridges that vary in size,
which are capable of providing physical signs that can directly
affect cell behaviour [30–33]. The ECM is composed of
proteins such as fibrous collagen, fibronectin, proteoglycans,
laminin fibres, and hyaluronic acid, which gives the nat-
ural scaffold its chemical, mechanical, and topographical
signals that are needed to influence cell behaviour [34].
Therefore, it is important when developing 3D scaffolds
that the scaffold biomimics features of biological tissues
either compositionally or structurally so that the scaffold can
replicate the regeneration process in a similar way to nature.
For example, the scaffold topography can directly influence
growth parameters responsible for cell adhesion, apoptosis,
differentiation, genetic expression, migration, morphology,
orientation, and proliferation [35, 36].
In particular, topological features provide contact guid-
ance for the cell, which influences the cytoskeletal arrange-
ment and adhesion of the cell [37]. Historically, Harrison
was the first to observe the interaction between a substrate’s
topography and cellular tissue when investigating spider silk
fibres in 1911 [38]. The nerve cells tended to grow in a
bipolar shape orientated along the fibres. The term “contact
guidance” was later coined by Weiss in 1945 to describe
the effect of the fibres on cell orientation and proliferation
[39, 40]. Recently, Allmeling et al. have investigated the
column growth of Schwann cells along the length of spider
silk fibres for a possible nerve conduit and found that the
structure promoted successful cell adhesion and migration
[41]. Studies of other cultivated cells on different planar
scaffold materials, containing arrays of micrometer-sized
protrusions have promoted cell attachment and reduced cell
proliferation [42]. These studies have clearly demonstrated
that controlling the surface features of the scaffold in a
specific way can directly influence cellular adhesion, protein
absorption, proliferation, and morphology. In addition, cells
also have the ability to transform theirmicroenvironments on
the scaffold structure by changing the ECM it produces. This
can be done by synthesizing or degrading the ECM, secreting
cytokines, and communicating with other cells andmatrix on
the scaffold by molecular and physical signals [43]. It is clear
that the interaction between the individual cells, the ECM,
and the nanotopographic surface features of the scaffold is a
dynamic process and is crucial to fully understand the cellular
response as a whole in developing suitable biomaterials for
tissue engineering.
3. Construction of a Tissue Scaffold
The scaffold architecture used in tissue engineering has three
distinct size ranges. The first is the superstructure; this size
range essentially covers the overall shape and dimensions of
the scaffold. The second is the microstructure, which refers
to the scaffold surface features at the cellular level and final
size range is the nanostructure, which refers to the subcellular
features of the scaffold surface [35]. Generally, biomaterials
used in tissue engineering applications such as tissue repair
and regeneration have generally favoured bioinert materials
for permanent bioimplants such as hip and knee replace-
ments [44]. In the case of scaffolding materials, both natural
and inorganic, includingmetal oxides, have been investigated
[45]. The selection of the material used to manufacture the
scaffold is an important factor in its successful application.
A wide variety of natural biodegradable materials have been
extensively studied for potential use in tissue engineering
since the body’s natural pathways can effectively deal with
the by-products resulting from their breakdown. Natural
polymers such as polysaccharides [46–50], chitosan [51–
56], hyaluronic-based derivatives [57–60], and protein-based
materials such as fibrin gel [61, 62] and collagen [63–66]
have all shown some positive outcomes during investigative
trials. However, on the whole, these polymeric materials
lack sufficient mechanical strength to effectively support
tissue growth in the body environment. On the other hand,
inorganic or synthetic biodegradable polymers have been
fabricated under controlled conditions to produce a variety
of scaffold structures with selectable, predictable mechanical,
and physical properties.
Biopolymer materials are composed of simple, high-
purity constituent monomers. An advantage of biopolymers
is that they have a controllable degradation rate within the
body’s environment and their reactions to the body fluids
during degradation produce low toxicity by-products that can
easily be handled by the bodily excretory functions. Examples
of these bulk biodegradable polymers include poly-(lactic
acid) (PLA) [67–72], poly(l-lactic acid) (PLLA) [65, 73–
75] poly(lactic-co-glycolic acid) (PLGA) [76–79], polycapro-
lactone (PCL) [74, 80–82], and poly(glycolic acid) (PGA)
[83–86]. These are generally poly-𝛼-hydroxy esters that de-
esterify in the body environment as the polymer slowly
degrades to produce simple metabolites [87]. An example
of biopolymers currently in use is the biodegradable sutures
composed of PLA and PLG that are employed in medical
procedures. Because polymers are such good biocompatible
materials, they have also been extensively investigated for
the controlled delivery of drugs to specific organs within the
body [88–90]. In general, polymers are strong and can be
fabricated into a variety of different shapes and structures,
such as, disks, fibres, films, and pellets, as required for
the specific application. In addition, they can be produced
with microtypographical surface features that can effectively
induce physical cues that can enhance cell interaction with
the surface of the scaffold.
Another promising material with new and novel prop-
erties for biomedical applications is polyhedral oligomeric
silsesquioxane (POSS). The material structure consists of
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an inner inorganic framework of silicon and oxygen atoms
which form a nanometre size cage. Surrounding the cage is
an outer shell of organic groups which can be composed of
hydrogen, alkyl, alkene, and arylene. The biomedical appli-
cations of POSS arise from the materials biocompatibility,
biostability nontoxicity, cytocompatibility, and resistance to
degradation [91–93]. It is due to these properties that POSS
has been incorporated into wide range of nanostructured
copolymers for a number of biomedical applications such as
biomedical devices (heart valves, coronary stents) [94, 95],
drug delivery [96], and tissue engineering [92].
Inorganic materials such as bioglass, ceramics, and metal
oxides have also been investigated for possible use in tissue
engineering applications.This research stream stems from the
fact that despite the successful application of polymers, there
are still some unresolved issues that need to be resolved. The
first issue stems from the local inflammatory response of the
surrounding tissues to the presence of the polymer material,
and the second results from the uneven degradation process
of polymer used in the scaffold. In spite of this, polymer
scaffolds are superior to both ceramic and metal oxides for
soft tissue applications such as skeletalmuscle, cardiovascular
tissue, and skin substitutes. The advantage of using polymers
in soft tissue applications stems from their close chemical
and physical similarity to natural cellular tissues [97–99].
Studies using bioactive glass as a scaffold material have
revealed that when the glass was seeded with osteoblasts,
there was an enhancement of cellular proliferation [100].
Furthermore, metals such as pure tantalum (Ta) have also
been successfully used to produce tissue scaffolds for the
adhesion, growth, and differentiation of osteoblasts. One
innovative technique used to create a Ta scaffold begins
with the pyrolysis of polyurethane foam [101]. The foam
turns into a low-density carbonaceous skeleton composed
of a repeating dodecahedron structure that produces an
interconnecting array of pores. In the next stage, a chemical
vapour deposition/infiltration technique (CVD/CVI) is used
to deposit pure Ta onto the carbon skeleton and produce a
porous metal scaffold. The structural integrity of the scaffold
increases as the deposition process continues. An advantage
of this deposition process results in the formation of a
crystallographic growth pattern that orientates the Ta layer to
form a microtextured surface, which is similar to cancellous
bone [102, 103]. In addition, by changing the characteristics of
the precursor polymer used and the thickness of the Ta layer
deposited onto the carbon skeleton it is possible to control
the size of the pores produced. For orthopaedic applications,
the thickness of the Ta layer ranges from 40 to 60𝜇m, while
the pore size ranges from 400 to 600𝜇m, and the resulting
scaffold porosity can vary from75% to 80%.Thehigh porosity
and large pore size are ideal for deep and extensive vascular
tissue penetration, which results in strong tissue attachment
strengths [104]. This type of vascular tissue penetration and
subsequent growth has also been seen in images of highly
porous alumina ceramic foam metals [105]. Furthermore,
studies into the growth of osteoblasts onmetal oxide surfaces
such as nano-porous alumina have also shown a positive
response [106, 107].
3.1. Important Parameters Needed for a Successful Scaffold
Structure. The operational demands that are placed on a
substrate’s scaffold structure when implanted into the body
environment are numerous, and the scaffold must overcome
many challenges to achieve a successful clinical outcome.
For example, the biocompatibility of the scaffold material
is crucial in preventing any cytotoxicity, immunological
reactions, and inflammation responses from the body [108–
110]. This is particularly important since the presence of any
scaffoldmaterial within the body environment will initiate an
inflammatory response at the scaffold site. As a consequence,
a complex biochemical cascade of events takes place in
which cells arrive and start producing chemokines, cytokines,
and growth factors to initiate the repair of damaged tissue
surrounding the scaffold site. The presence of these cells
on the surface of the scaffold can initiate a foreign body
reaction to biomaterial used to manufacture the scaffold.
These cells produce oxygen radicals and enzymes that have
the potential to degrade the scaffold which can ultimately
lead to the failure of the scaffold [111]. Recent in vitro and
in vivo studies by Lamers et al. have revealed that the
immunological response to a biomaterial surface could be
altered by introducing nanometre sized grooves to a substrate
surface [112]. The nanometre patterned surfaces were found
to solicit a response from murine macrophages (cell line
RAW264.7) which resulted in an altered gene expression and
protein secretion after 24 h in vitro. However, there was no
noticeable change in protein secretion during the in vivo
study. These studies highlight the importance of using a
biomaterial with appropriate surface topography to solicit a
favourable immunological outcome, since the macrophages
were clearly sensitive to the nanometre scale groove features
and may assist in the healing process. The scaffold provides
the initial framework for the seeded cells to attach, proliferate,
and differentiate. During this process, the initial scaffold
mimics the ECM environment, and as new ECM, is being
created by the cells, it will provide integrity to the new
tissues as the scaffold slowly degrades over time. The surface
chemistry of the scaffold material is an important factor
during the formation of new ECM, since the scaffold must
be chemically compatible with the ECM. Since the ECM is
nature’s own tissue scaffold and forms the cell environment,
it is desirable that any engineered scaffold biomimics the
ECM as close as possible. This is because the chemistry and
topography of the ECM provides the cues that initiate and
modulate cell adhesion, cellular interaction, proliferation,
and migration [30, 64, 113–118].
In exploring their surrounding environment, cells receive
a variety of complex biochemical and biophysical signals
via filopodia at the cell boundaries which spread out over
the surface of the ECM [117]. To accomplish a number of
biological processes, cell movement, andmigrationmust take
place. The cell achieves motion through the action of protru-
sions from the cell membrane, forming integrin adhesions
combined with cellular contractions. The direction of cell
motion is guided by environmental stimuli such as biochem-
ical and biophysical signals. In addition, cells also respond to
mechanical stimuli in the form of gradients in themechanical
stiffness or rigidity of the substrate—a phenomena known as
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durotaxis that results in cell membrane stretch, compression,
and interaction with the surface topography [119–121]. Cells
that come in contact with stiff substrates develop strong focal
adhesions that securely anchor the cell to the substrate. This
is in contrast to soft substrates which induce small, transitory
adhesions that are unstable and provide weak anchorage for
the cell. In effect, durotaxis creates a bias that influences
the direction of cell migration from softer substrate regions
towards regions that are characterised by increasing elasticity
or stiffness [122]. For instance, multipotent mesenchymal
stem cells (MSCs) display lineage-specific differentiation
when cultured on substrates that mimic the stiffness of
native tissue environments. In the case of MSCs cultured on
substrate thatmimics the bone environment, the cells become
osteogenic. While MSCs exposed to substrates that mimic a
myogenic tissue environment become muscle cells [123, 124].
In addition, the biomaterial needs to be able to prevent
any rapid bulk degradation effects that might result in the
formation of voids and defects within the scaffold structure.
Another important property of a biomaterial is its ability to be
easily sterilized prior to its applicationwithout any significant
changes to its surface chemistry [64, 125–128]. Also, the
biomaterials used in the construction of the scaffold should
not be hydrophobic, since the wettability of the material is
an important factor that must be carefully considered for
successful cellular adhesion and attachment. At themolecular
level, it is extremely important that the scaffold contains a
network of pores and interconnecting channels to facilitate
the diffusion of nutrients, oxygen, metabolites, and waste
products. Kim and Coulombe were able to demonstrate that
pore size and a high surface area to volume ratio were
important parameters that encouraged cell penetration and
subsequent growth in the scaffold structure to form cellular
associations [129]. In addition, if the scaffold structure is
going to be rather large, then the structure should be designed
to contain a life-supporting capillary-like network as an
integral part of the scaffold. Furthermore, the interactions
between the cellmicrometre scale topography andnanometre
scale topography of the scaffold structure can influence cell
attachment and adhesion, proliferation, and migration. A
recent investigation by Andersson et al. revealed a link
between epithelial cell attachments to surfaces of similar
chemistry and that the cellmorphology and cytokine produc-
tion were strongly dependent on the underlying nanometre
scale TiO
2
deposited surface topography [130].
3.2. Scaffold Manufacturing Techniques. The cells in the
human body are micrometre sized objects, with the largest
cells being the anterior horn in the spinal cord (∼135 𝜇m)
and the smallest being the granule cells in the cerebellum
(∼4 𝜇m), with a typical cell size between 10 to 20 𝜇m [131].
While the topography created by the ECM proteins are
generally in the submicrometre to nanometre size range.This
size range has been shown to have an influence over cell
behaviour at the cellular level [132]. Since cells are responsive
to the topography of the ECM, engineered scaffolds and
substrates must also display similar surface topographical
features that can provide effective signals to influence cellular
behaviour. In addition, the size, density, and distribution of
the topographical features found on the surface of the ECM
are also dependent upon the types of cellular tissues that
form the ECM [32, 133]. Therefore, it is important that the
information derived from the specific cell generated ECM
topography is translated into an effective fabrication process
that replicates these surface features onto tissue culture
substrates and scaffolds [134].
There are three main categories used to define the type
of topographical features that can be fabricated, the first is
ordered,which involves the production of accurate repeatable
surface features and the second involves the formation of
irregular or unordered features such as surface roughening
and fibrils [35, 135]. Both of these categories attempt to
replicate the topographical features of the ordered ECM, the
third involves the removal of cells from body tissues and then
use the native decellularized tissues as cell culture scaffolds
[136].
Biological scaffolds composed of decellularized tissues
and organs are capable of providing a natural ECM structure
that can be used for a variety of tissue engineering appli-
cations [137–139]. The ECM harvested from a number of
tissue sources are then used in a number of tissue engineering
applications such as blood vessels [140, 141], heart valves
[142, 143], urinary bladder [144, 145], small intestinal sub-
mucosa [146, 147], liver [148, 149], skin [150], and lung [151].
If properly prepared, the decellularized tissue scaffold can
preserve much of the original ECM structure and bioactive
functional molecules, which enables the scaffold to provide
important physical and chemical signals needed to support
cell functions such as attachment, differentiation, and pro-
liferation. The use of biological derived tissues as scaffold
structures has the potential to create an effective environment
to induce cellular growth. To date, decellularized ECM
scaffolds have been described for a number of organs, with an
engineered bioartificial heart being investigated in vivo using
an animal model [152].
During the late 1970’s and early 1980’s with the develop-
ment of cellular telephones, digital devices and the personnel
computer in the electronics industry, it was possible to
develop many novel micrometre and later, nanometre scale
fabrication techniques to manufacture extremely small and
compact equipment. Using these new fabrication techniques
in conjunction with the continually developing biomaterials
field, many research teams across the world have the poten-
tial to fabricate 3D scaffold structures that can effectively
biomimic the topographical features of the ECM. Once the
specific tissue engineering application has been identified, the
required chemical, physical, and mechanical properties can
be determined and then a suitable fabrication technique can
be selected to manufacture the scaffold structure.
Technologically driven top down micrometre and na-
nometre scale lithographic fabrication techniques have been
used to produce a variety of topographical features such
as grooves, gratings, pillars, spheres, pits, and tubes (see
Figure 2). These techniques have the ability to control the
fabrication of accurate and highly reproducible topographical
features over the surface of a variety of substrates. Sev-
eral lithographic techniques have developed over the years
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Figure 2: Some typical topographical surface features.
that have enabled researchers to explore a variety of cell-
topography interactions on materials such as silicon, poly-
mers, and titanium [132]. Electron beam lithography, which
was originally developed for producing integrated circuits
has been successfully used to produce both micrometre and
nanometre scale topographical features on the surface of
several biocompatible materials. However, this technique is
relatively expensive and time consuming due to substrate
exposure time, which limits the production of substrates and
scaffolds [153]. Photolithography is a process which selec-
tively removes predetermined material from the surface of a
substrate to fabricate micrometre topography.The first use of
this technique for cell response studies was made in the early
1980s when a series of micrometre scale grooves were formed
in the surface of a silica substrate [154].Other techniques such
as X-ray lithography, laser ablation, nanoimprinting, and
microcontact lithography have also been used effectively used
to produce topographical features on a variety of materials.
Two recent techniques that may provide improved routes
for the fabrication of 3D cellular scaffolds for a variety of
tissue engineering applications are self-folding materials and
multiphoton lithography. Micrometre scale fabrication of
3D structures by controlled out of the plane self folding of
2D patterns using a laser direct-write-based technique has
the potential to create elaborate and precisely structured
substrates that can be used to model in vivo cell behaviour
[155]. The Japanese art of paper folding known as origami
transforms 2D patterns into 3D shapes. A similar approach
uses self-folding, a self-assembly process in which planar
structures fold up from the 2D substrate when exposed to
specific activation stimuli [156]. For example, laser origami
uses a laser direct-write technique to produce feature through
laser fabrication of the pattern in the substrate, then deposit
the active elements on the pattern via laser transfer or cutting
and finally the substrate is heated using the laser which
results in the cut patterns folding up out of the substrate
[156]. The other recent technique is Multiphoton lithography
(MPL) which can be used to fabricate 3D tissue scaffold
structures. It is a computer controlled fabrication technique
in which the morphological features of a biological structure
are programmed as stack of 2D tomographic cross sections.
The cross sections act as input for a sequence of reflective
photomasks that are used to direct the replication of the
biological structure. The direct-write process, using a laser,
translates the programmed data from the cross sections into
a protein-based 3D reproduction of the original biological
structure [157]. This technique is capable of producing com-
plex 3D structures with well defined architectural features
such as size, shape, inter connectivity, branching, geometry,
and orientation that have the potential to mimic complex
3D biological structures [157]. Many of these top down
techniques tend to be very expensive since they require spe-
cialised instrumentation and equipment, complex ultrahigh
vacuum systems, and clean room facilities.
On the other hand, the electrospinning process, which
was originally developed by the textile industry, has beenused
for the past 100 years. Refinements of the technique in the
last decade have seen it increasingly used in the manufacture
of fibre with diameters ranging in size from many microns
to tens of nanometres [158]. The fibres produced are used to
form a nano-fibrous porous structure that permits cells to
enter the scaffold, while allowing the flow of nutrients and
waste products from the cells [159, 160]. Scaffold structures of
synthetic polymers such as PLA and PLGA, and natural poly-
mers such as collagen (types I, II, III), chitosan, elastin, fibrin,
and silk have been produced using this technique. Agarwal et
al. have demonstrated that polymericmaterialsmanufactured
using this technique induce a favourable and conducive
response from the cells during attachment and subsequent
proliferation [66].The favourable and conducive responses of
the scaffold to the cells can be further enhanced bymodifying
properties such as fibre diameter, porosity, and morphology
by simply adjusting the electrospinning conditions. Further
enhancement of the electrospunmaterial can also be achieved
by modifying the fibres to resemble the ECM at the nanome-
tre scale level. This technique involves coating the polymeric
fibres with collagen macromolecules, but this process is still
evolving, and there are still many challenges ahead.
The phase separation/emulsification technique has been
used to produce scaffold structures using a suitable polymeric
material [161, 162]. This method is based on the principles
of phase separation, for example, PLGA is dissolved in
methylene chloride and then by adding water produces an
emulsion. This mixture is then poured into a mould and
freeze-dried, during which both the water and methylene
chloride are removed leaving a highly porous scaffold struc-
ture [163]. Recent developments in this technique have pro-
duced scaffolds with nanometre scale topographical features
abrading the surface, which have resulted in an enhanced
cell response to this material [126, 164, 165]. Similar investi-
gations carried out by Ma have revealed that nanopolymers
produced using this technique have a distinct advantage
in terms of the increased surface area and the resulting
enhanced 3D connectivity for various cell types used in tissue
engineering applications [88, 166]. Other techniques such
as micelle lithography, polymer de-mixing, chemical vapour
deposition, chemical etching, and anodization have all been
used to produce scaffolds with topographical features capable
of soliciting a positive cellular response [35, 167–170].
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4. Cell Response and Behaviour to
Surface Topography
4.1. Micrometre Scale Topography. With the advent of tissue
engineering in the mid-1980s, various fabrication techniques
have been used to produce a variety of cell culture substrates
and scaffolds to meet the high demands for regenerated
tissues. Since then there has been a considerable amount
of research into the interactive relationship between cells
and micrometre scale surface topography of substrates and
scaffold structures. Many studies have reported the influence
of submicrometre to nanometre scale topographical features,
which are smaller than the size of the cell, on cell adhesion,
migration, proliferation, and morphology. These features
have size ranges that are similar to the size and topography
of proteins found in the ECM [171–179]. And recently, Dalby
et al. showed that the interaction of fibroblast cell filopodia
with surface features as small as 10 nm directly influenced
cell adhesion [180]. Being able to create precise topographical
features has made it possible for researchers to investigate
the interaction between surface topography and cellular
behaviour such as contact guidance [181–187]. The most
commonly studied topographical feature is the groove, and
its dimensions can provide physical signals to orientate the
cell. For example, human gingival cells seeded in micrometre
scale grooves fabricated in a silica substrate produced cellular
growth that was aligned with the grooved topography [154].
Subsequent investigation found that increasing the depth of
the groove enhanced cell alignment, while increasing groove
width produced less cell alignment [174]. In addition, in a
similar study, mesenchymal cells grown on quartz substrates
attach to the ridges of the grooves and then spread via
bridging the ridges. The cells not only aligned themselves
parallel with the grooves, but they also migrated between 3
to 5 times faster than those on smooth level surfaces [188].
The influence of the topographical feature can have a
significant effect on the cell and in some cases dominate
other substrate signals such as surface chemistry. Neurons
cultured on substrates with a number of protein (laminin)
tracks, orientated perpendicular to a range of grooves with
varying depths revealed that the neurites aligned themselves
with the protein cuewhen the grooveswere shallow.However,
when the groove depths were greater than 500 nm the
topographical feature became the dominant influence on
cell alignment [189]. Furthermore in a similar study, the
influential dominance of topography in manipulating and
orientating cells was further demonstrated when osteoblasts
were aligned by surface grooves rather than chemical cues
[190]. Not all cell lines orientate themselves with the groove
or ridge, this behaviour is dependent on the topography
and the cell type. For example, embryonic rat spinal cord
and hippocampus neurons cultured on grooved patterned
quartz substrates revealed that neurite spreading was gov-
erned by dimensions of the groove and the cell type. The
neurites of the spinal neurons tended to orientate themselves
with the geometry of the groove, while the neurites of
the hippocampus neurons tended to grow perpendicular
to shallow grooves and align themselves with deep wide
grooves [191]. Similar cell response studies have investigated
different surface topographical features such as gratings,
posts, fibres, pores, wells and spheres [114, 150, 174, 192].
For example studies by Green et al. showed that a smooth
substrate surface covered with evenly distributed 5 𝜇m diam-
eter pores enhanced the proliferation of human fibroblast
cells compared to a similar surface with pore diameters of
10 𝜇m [185]. While a study investigating the diameter and
depth of a micrometre scaled well pattern evenly distributed
on a smooth polydimethylsiloxane (PDMS) substrate found
that by increasing the well diameter produced decreasing
numbers of fibroblasts attaching to the surface [193].
4.2. Nanometre Scale Topography. Various studies have
shown that nanometre scale topography is an important fac-
tor that influences protein adsorption, which in turnmediates
the interaction between the cellular environment and the
surface of the biomaterial [194–198]. Nanometre scale topog-
raphy tends to biomimic the cell and modulating signals that
are normally found in the 5 to 200 nm features that form part
of the ECM structure [114].The conformation of the adsorbed
protein layer on the surface is critical for cell integrins to
effectively interact with the underlining surface topography.
These interactions are complex and result from local changes
in surface properties such as chemistry, protein orientation
and adsorption, wettability, and roughness [199]. Effects from
surface features such as pits, pores, fibres, grooves, gratings,
and spheres all increase the surface area and roughness of the
substrate, which influences surface wettability, changes the
local surface chemistry, and influences protein adsorption to
the nanometre scale surface topography [200]. In addition,
proteins with dimensions similar to those of the nanometre
scale topographical features are not structurally changed by
the surface, while surface features that are smaller or greater
than the protein tend to influence the structural arrangement
of the proteins during adsorption.This results in the proteins
conforming to the nanometre scale topography of the surface
[201]. Also, nanometre scale topographical features such as
grooves, gratings, pits, and pores have the ability to provide
sites for protein deposition, which can enhance contact
guidance to cells during attachment [202–205].
The ability of cells to recognise and interact with nanome-
tre scale surface topography has been examined using a
variety of cell types and different surfaces and surface
features. For example, Figure 3 presents optical and field
emission scanning electron microscopy images of Cos-7,
Vero and MDCK cell lines cultured on a self-organized
hexagonal array of 110 nm diameter pores, electrochemically
formed in a porous anodic aluminiumoxidemembrane [169].
Endothelial cells cultured on polymer demixed substrates
produced a surface covered with islands of nanometre scale
heights of 13, 35, and 95 nm [206]. The 13 nm high islands
were found to have the most significant effect in assisting cell
spreading, while the effect of the 35 and 95 nm high islands
was less favourable.The cells found on all three surface mod-
ifications exhibited normal cell morphology and responded
favourably to the nanometre scale topographical features,
with proliferation rates higher than on an equivalent flat
control surface [207]. Topographical features on the surface
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Figure 3: Optical (left) and field emission scanning electron microscopy (right) images of Cos-7 (a, b), Vero (c, d), andMadin-Darby Canine
Kidney (e, f) cell lines showing attachment to the electrochemically engineered Anodic Aluminium Oxide membrane. (Images taken by
Murdoch Applied Nanotechnology Research Group).
of the substrate can also create physical barriers for cell-to-
cell contact or the surface features that could restrain cell
spreading and influence cell morphology. The importance of
cell-to-cell contact is clearly demonstrated when endothelial
cells in contact with neighbouring cells produce significantly
higher proliferation rates than single cells without neighbour
contacts [208]. Epithelial cells cultured on a silicon oxide
substrate covered by 70 nm wide nanogrooves spaced at
400 nm apart, produced by electron beam lithography, were
found to align along the ridges of the groove. The cells
appear to adhere to the surface topology using the adhesion
properties of the lamellipodia and filopodia, which enables
the cells to spread over the substrate [204]. Fibroblast cells
have also been shown to respond to topographical surface
features on a textured substrate’s surface. Silica nanoparticles
placed onto a substrate to increase the nanoroughness profile
of the surface directly influences the behaviour of the cell’s
adhesion. Studies byCousins et al. have found that the surface
nanoroughness directly influences cell morphology, reduces
cell adhesion, and reduces proliferation [209]. In comparison
the response and behaviour of fibroblast cells changes with
island topographical features. Thus fibroblast cells cultured
on polymer demixed substrates with surface covered with
islands of nanometre scale heights of 10 and 13 nm have been
found to enhance cell adhesion and promote proliferation
[210]. However, when 50 and 95 nm high islands were
examined the topographical features sustained significantly
less fibroblast cell adhesion than the flat control surface
used. This clearly demonstrated that the size dependence
of the nanometre scale topographical feature influenced the
response and behaviour of the fibroblast cell [180]. On the
other hand, macrophage cells cultured on a fused silica with
10 to 282 nm nanogrooves induced greater phagocytosis than
cells grown on flat control substrates. Macrophages also
tended to adhere and spread perpendicular to the direction
of the grooves in the substrate [176]. Surface topographical
features can also influence the behaviour of osteoblast cells,
with many surface features and textures inducing greater
cell adhesion and proliferation [211]. In the case of an alu-
mina substrate surface with nanometre scale topographical
features, osteoblast cell numbers were up to three times
higher than a flat control alumina substrate [20, 212, 213].
In addition, the morphology of these osteoblasts can be
modulated by specific nanometre scale topographic features
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such as grooves, which cause the cells to elongate and align
themselves along the axis of the groove [214].
4.3. Influence of Micrometre and Nanometre Topographical
Features on Cells. Surface topography of a substrate can
present both micrometre and nanometre scale features to
cells that can induce changes within the cell. Studies have
shown that cells respond differently to surfaces with ordered
topographical features compared to surfaces with a dis-
ordered topographical landscape with a similar roughness
value. For example, a recent study by Ball et al. revealed
that the response of osteoblasts to ordered micrometre scale
topography was an increase in metabolic activity compared
to osteoblasts on disordered micrometre scale topograph-
ical substrates [111]. The results of the study indicate the
cellular responses to the substrate surfaces were influenced
primarily by the topography of the surfaces, and cells on
the ordered surfaces could spread or elongate successfully
whilst those on the rough surfaces were constrained. In
the case of multipotent mesenchymal stem cells (MSCs) a
certain amount of nanometre scale disorder has been found
to stimulate MSCs to produce bone minerals in vitro in the
albescence of any osteogenic supplements [121, 123].However,
there is conflicting work in the literature to whether an
ordered topography or a disordered topography is superior
in soliciting a favourable cellular response and for inducing
effective protein adsorption.
The conflicting research results in the research probably
stem from trying to replicate the ECM of the particular cell
type. The tissue engineered scaffold is an attempt to recreate
the ECM with all of its complicated signals and stimuli
that effectively solicit the appropriate cell response. The
surface topographical features whether ordered or disordered
are only part of creating a tissue scaffold that completely
replicates the nature tissue environment of a specific cell
type. And as discussed in this review each cell type responds
differently to various topographical features both at the
micrometre and nanometre scales. It may be the case that
some cell types such as osteoblasts may respond better to
an ordered topographical landscape with fixed dimensional
features than a disordered or random topography. This may
not be the case for all cell lines and it is only with future
studies that examine various substrate topographies and
materials will the ideal tissue scaffold be found that is cell
specific, provides optimum protein adsorption and provides
the most effective biochemical and biophysical signals to
induce cellular response.
5. Conclusion
Topographical features on the surface of a suitable sub-
strate can directly influence and affect cellular behaviour.
The landscape of the substrate can influence cell adhesion,
surface orientation, morphology, cytoskeletal development,
differentiation, and proliferation. The surface topography at
the nanometre scale tends to induce cell-protein responses
which are similar to the signals given by its native ECM.
The conformation of an adsorbed protein layer on the
surface is critical for cell receptors to effectively interact
with the underlining surface topography. Substrate surface
topography at the micrometre scale, which has dimensions
comparable to cells, has the ability to influence cell adhesion,
morphology, and contact guidance. Generally, cells do not
penetrate surface features such as microgrooves smaller than
2 𝜇m in width or 500 nm in depth [202]. However, this
micrometre scale tendency is cell-dependent and can vary
between cell types. On the other hand nanometre scale
topography influences cell orientation on the substrate [215,
216]. During cell orientation filopodia provide details of the
underlying surface nanometre scale topography. However,
the recognition of the nanometre scale topography and how
this information is signalled and interpreted by the cell is still
an area of active investigation. Nevertheless, it is clear that
any future substrate or scaffold structure for a specific tissue
engineering application needs to take into account the cell
type, selection of the most suitable biomaterial, and also take
into account the effects of both micrometre and nanometre
surface topography to solicit the most favourable cellular
response for a successful clinical outcome.
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